StonvexLoading…
StonvexStonvexStonvexCore line items from VRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $3.41B | $2.65B | $10.23B | $7.35B | $4.67B |
Operating Income | Not available | $440.10M | $1.83B | $1.25B | $733.10M |
Net Income | Not available | $390.10M | $1.33B | $887.20M | $324.20M |
EPS (Diluted) | $1.44 | $0.99 | $3.41 | $2.27 | $1.25 |
Total Assets | Not available | $13.40B | $12.21B | $10.82B | $10.41B |
Total Liabilities | Not available | $9.16B | $8.27B | $7.31B | $7.28B |
Cash & Equivalents | Not available | $2.15B | $1.73B | $1.40B | $1.64B |
Free Cash Flow OCF − CapEx | Not available | $654.20M | $1.89B | $1.01B | $544.70M |
Shares Outstanding | Not available | 383.95M | 382.55M | 382.26M | 381.80M |